Brentville, Victoria A.

Cancer Vaccines, Adjuvants, and Delivery Systems

Paston, S. J., Brentville, V. A., Symonds, P., & Durrant, L. G. (2021) · Frontiers in Immunology

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 200

Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell–Mediated Antitumor Immunity

Brentville, V. A., Metheringham, R. L., Gunn, B., Symonds, P., Daniels, I., Gijon, M., Cook, K., Xue, W., & Durrant, L. G. (2016) · Cancer Research

Immunotherapy and Immune ResponsesT-cell and B-cell Immunology

Cited by 98

Post-translational modifications such as citrullination are excellent targets for cancer therapy

Brentville, V. A., Vankemmelbeke, M., Metheringham, R. L., & Durrant, L. G. (2020) · Seminars in Immunology

Immunotherapy and Immune ResponsesT-cell and B-cell Immunology

Cited by 53

Modi-2 a vaccine stimulating CD4 responses to homocitrullinated self epitopes as therapy for solid cancers

Al-Omari, A. A., Cook, K. W., Symonds, P., Skinner, A., Wright, A., Zhu, Y., Coble, V. L., Mohammed, O. J., Choudhury, R. H., Uddin, N., et al. (2024) · npj Vaccines

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 0